| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Cipla Ltd
| NSE
|
CIPLA
|
309.30
|
|
-0.35
(-0.11%)
| 248.34B
|
|
|
Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31
, 2011, the Company introduced a number of new drugs and formulations, ...
| |
| |
|
|
Cipla Ltd
| BOM
|
500087
|
309.15
|
|
-0.85
(-0.27%)
| 248.22B
|
|
|
Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31
, 2011, the Company introduced a number of new drugs and formulations, ...
| |
| |
|
|
Cipla Limited (ADR)
| PINK
|
CPLFY
|
|
|
|
|
|
|
Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31
, 2011, the Company introduced a number of new drugs and formulations, ...
| |
| |
|
|
InterMune, Inc.
| NASDAQ
|
ITMN
|
10.73
|
|
+0.54
(5.30%)
| 700.22M
|
|
|
InterMune, Inc. (InterMune) is a biotechnology company focused on the research,
development and commercialization of therapies in pulmonology and orphan ...
| |
| |
|
|
Panama Petrochem Ltd.
| BOM
|
524820
|
154.05
|
|
-5.45
(-3.42%)
| 1.35B
|
|
|
Panama Petrochem Limited is an India-based company. The Company manufactures and
exports petroleum specialty products. It has four manufacturing units in ...
| |
| |
|
|
Ankur Drugs and Pharma Ltd.
| BOM
|
531683
|
11.34
|
|
-0.10
(-0.87%)
| 219.33M
|
|
|
Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of
pharmaceuticals formulations. As of March 31, 2010, it had three manufacturing
units: two ...
| |
| |
|
|
Ankur Drugs and Pharma Ltd.
| NSE
|
ANKURDRUGS
|
11.35
|
|
-0.10
(-0.87%)
| 219.53M
|
|
|
Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of
pharmaceuticals formulations. As of March 31, 2010, it had three manufacturing
units: two ...
| |
| |
|
|
Panama Petrochem Ltd.
| NSE
|
PANAMAPET
|
154.35
|
|
-5.50
(-3.44%)
| 1.35B
|
|
|
Panama Petrochem Limited is an India-based company. The Company manufactures and
exports petroleum specialty products. It has four manufacturing units in ...
| |
| |
|
